Literature DB >> 6244463

The effect of portacaval shunt upon hepatic cholesterol synthesis and cyclic AMP in dogs and baboons.

A Francavilla, A F Jones, J Benichou, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6244463      PMCID： PMC3005364          DOI： 10.1016/0022-4804(80)90074-8

Source DB:  PubMed          Journal:  J Surg Res        ISSN： 0022-4804            Impact factor:   2.192


× No keyword cloud information.
  35 in total

1.  Regulation of the diurnal rhythm of rat liver beta-hydroxy-beta-methylglutaryl coenzmye A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone.

Authors:  C M Nepokroeff; M R Lakshmanan; G C Ness; R E Dugan; J W Porter
Journal:  Arch Biochem Biophys       Date:  1974-02       Impact factor: 4.013

2.  Evidence for regulatin of cholesterol and fatty acid synthesis in liver by cyclic adenosine 3',5'-monophosphate.

Authors:  L A Bricker; G S Levey
Journal:  J Biol Chem       Date:  1972-08-10       Impact factor: 5.157

3.  Inhibition of hepatic lipogenesis by cyclic-3',5'-nucleotide monophosphates.

Authors:  J B Allred; K L Roehrig
Journal:  Biochem Biophys Res Commun       Date:  1972-02-16       Impact factor: 3.575

4.  Portacaval shunt in hyperlipoproteinaemia.

Authors:  T E Starzl; C W Putnam; H P Chase; K A Porter
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

5.  Properties of cyclic 3',5'-nucleotide phosphodiesterase from rat brain.

Authors:  W Y Cheung
Journal:  Biochemistry       Date:  1967-04       Impact factor: 3.162

6.  Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting.

Authors:  R Sherwin; P Joshi; R Hendler; P Felig; H O Conn
Journal:  N Engl J Med       Date:  1974-01-31       Impact factor: 91.245

Review 7.  Liver diseases and diabetes mellitus.

Authors:  W Creutzfeldt; H Frerichs; K Sickinger
Journal:  Prog Liver Dis       Date:  1970

8.  Elevated plasma glucagon levels in cirrhosis of the liver.

Authors:  J Marco; J Diego; M L Villanueva; M Diaz-Fierros; I Valverde; J M Segovia
Journal:  N Engl J Med       Date:  1973-11-22       Impact factor: 91.245

9.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

10.  Metabolic consequences of portacaval shunting in the rat: effects on glucose tolerance and serum immunoreactive insulin response.

Authors:  J P Assal; R Levrat; W Stauffacher; A E Renold
Journal:  Metabolism       Date:  1971-09       Impact factor: 8.694
View more
  5 in total

1.  Cyclosporine and liver regeneration studied by in vivo 31P nuclear magnetic resonance spectroscopy.

Authors:  L Rossaro; V Mazzaferro; C L Scotti-Foglieni; K A Porter; D S Williams; E Simplaceanu; V Simplaceanu; A Francavilla; T E Starzl; C Ho
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

Review 2.  Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.

Authors:  Robert L Rodgers
Journal:  Physiol Rep       Date:  2022-05

3.  Portacaval shunt in patients with familial hypercholesterolemia.

Authors:  T E Starzl; H P Chase; E H Ahrens; D J McNamara; D W Bilheimer; E J Schaefer; J Rey; K A Porter; E Stein; A Francavilla; L N Benson
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

4.  Morphologic and biochemical changes in dogs after portacaval shunt plus bile fistula or ileal bypass: failure of bile fistula or ileal bypass to prevent hepatocyte atrophy.

Authors:  J S Thompson; K A Porter; N Hayashida; D J McNamara; T S Parker; W J Russell; A Francavilla; T E Starzl
Journal:  Hepatology       Date:  1983 Jul-Aug       Impact factor: 17.425

5.  The Eck fistula in animals and humans.

Authors:  T E Starzl; K A Porter; A Francavilla
Journal:  Curr Probl Surg       Date:  1983-11       Impact factor: 1.909
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.